Delivery Order SPE2DB20D3303-SPE2DB25FA1TW
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,711.30 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supplies to be performed at the awardee's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid injection used for joint pain management, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,892.93 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes (4 mL quantity) under a firm fixed price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based viscosupplement used for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $9,152.18. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date...
- This delivery order, awarded July 31, 2025, provides Monovisc 88 mg/4 mL syringes to the Defense Logistics Agency's Medical Supply Chain through AmerisourceBergen Drug Corp. The contract represents a firm fixed-price delivery order with a ceiling value of $5,980.14 and an ultimate completion date of August 1, 2025. The award was made through open competition with no set-aside designation, and performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.73 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML syringes (4 ML quantity) on August 12, 2025, with a completion date of August 13, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This firm fixed price delivery order, valued at $7,229.88, represents a non-set-aside award and is due for completion by August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Monovisc is a viscosupplement injection used in orthopedic and...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.96 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $8,318.78 delivery order to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a routine pharmaceutical supply delivery. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $9,013.11 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Monovisc 88 mg/4 ml syringes. The contract is a firm fixed-price delivery order with a completion date of August 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal medical...